Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis

AIMS: Targeting interleukin-1 (IL-1) represents a novel therapeutic approach to atherosclerosis. CANTOS demonstrated the benefits of IL-1β neutralization in patients post-myocardial infarction with residual inflammatory risk. Yet, some mouse data have shown a prominent role of IL-1α rather than IL-1...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Eur Heart J
मुख्य लेखकों: Vromman, Amélie, Ruvkun, Victoria, Shvartz, Eugenia, Wojtkiewicz, Gregory, Santos Masson, Gustavo, Tesmenitsky, Yevgenia, Folco, Eduardo, Gram, Hermann, Nahrendorf, Matthias, Swirski, Filip K, Sukhova, Galina K, Libby, Peter
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2019
विषय:
Basic Science
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6685323/
https://ncbi.nlm.nih.gov/pubmed/30698710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehz008
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन